These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6135105)

  • 21. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
    Belch JJ; Newman P; Drury JK; McKenzie F; Capell H; Leiberman P; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):313-5. PubMed ID: 6130329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raynaud's disease and prostacyclin.
    Kennerly D
    Ann Intern Med; 1983 Feb; 98(2):258. PubMed ID: 6337542
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of prostaglandins PGE1 and PGI2 in peripheral arterial ischemia.
    Cronenwett JL
    J Vasc Surg; 1986 Feb; 3(2):370-4. PubMed ID: 3511306
    [No Abstract]   [Full Text] [Related]  

  • 24. Total anomalous pulmonary venous connection to portal system: a new therapeutic role for prostaglandin E1?
    Bullaboy CA; Johnson DH; Azar H; Jennings RB
    Pediatr Cardiol; 1984; 5(2):115-6. PubMed ID: 6382187
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
    Kerins DM; Murray R; FitzGerald GA
    Prog Hemost Thromb; 1991; 10():307-37. PubMed ID: 1848945
    [No Abstract]   [Full Text] [Related]  

  • 26. Administration of E-type prostaglandins in ductus-dependent congenital heart disease.
    Silove ED
    Pediatr Cardiol; 1982; 2(4):303-5. PubMed ID: 6956847
    [No Abstract]   [Full Text] [Related]  

  • 27. Epoprostenol and severe arterial disease.
    Olsson AG
    Lancet; 1983 Mar; 1(8326 Pt 1):711-2. PubMed ID: 6132070
    [No Abstract]   [Full Text] [Related]  

  • 28. Analysis of potential beneficial actions of prostaglandins in traumatic shock.
    Lefer AM; Araki H
    Prog Clin Biol Res; 1983; 111():199-210. PubMed ID: 6346328
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension.
    Watkins WD; Peterson MB; Crone RK; Shannon DC; Levine L
    Lancet; 1980 May; 1(8177):1083. PubMed ID: 6103414
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostaglandin E1 therapy for peripheral vascular disease is better than placebo.
    Clin Physiol; 1982 Apr; 2(2):163-5. PubMed ID: 7044658
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation].
    van der Sijp JR; Rohmer J
    Tijdschr Kindergeneeskd; 1985 Feb; 53(1):20-5. PubMed ID: 3857721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E1 in obstructive peripheral vascular disease.
    Fernandez NA; Rosenberg V; Lee M; Singer A
    Mt Sinai J Med; 1983; 50(3):213-7. PubMed ID: 6604865
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostaglandin E1 in severe Raynaud's phenomenon.
    Pardy BJ; Hoare MC; Eastcott HH; Miles CC; Needham TN; Harbourne T; Ellis BW
    Surgery; 1982 Dec; 92(6):953-65. PubMed ID: 6890719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of prostaglandins as local antithrombotic agents in microvascular surgery.
    Leung PC; Chan MY; Roberts MB
    Br J Plast Surg; 1981 Jan; 34(1):38-40. PubMed ID: 7006722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of vasospastic disease with prostaglandin E1.
    Clifford PC; Martin MF; Sheddon EJ; Kirby JD; Baird RN; Dieppe PA
    Br Med J; 1980 Oct; 281(6247):1031-4. PubMed ID: 7427564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin therapy for peripheral vascular disease - better than placebo?
    Wennmalm A
    Clin Physiol; 1982 Apr; 2(2):85-7. PubMed ID: 7044659
    [No Abstract]   [Full Text] [Related]  

  • 38. Remission of secondary Raynaud phenomenon using intra-arterial prostaglandin E1 infusion. A case report.
    Seemann J; Scholz J; Sielwicz M
    Int Orthop; 1994; 18(6):372-4. PubMed ID: 7698870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostacyclin therapy of peripheral artery disease].
    Kusaba A
    Kokyu To Junkan; 1985 Jul; 33(7):871-6. PubMed ID: 3903902
    [No Abstract]   [Full Text] [Related]  

  • 40. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
    DiGiovanni RL; Littlefield JM; Good RG
    J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.